Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Esther M. Pluijms"'
Autor:
Esther M. Pluijms, Astrid M. Kamperman, Witte J. G. Hoogendijk, Walter W. van den Broek, Tom K. Birkenhäger
Publikováno v:
Acta Psychiatrica Scandinavica, 145(5), 517-528. Wiley-Blackwell Publishing Ltd
Acta psychiatrica Scandinavica
Acta psychiatrica Scandinavica
Objective: There is limited evidence that adding an antidepressant to electroconvulsive therapy (ECT), compared with ECT monotherapy, improves outcomes. We aimed to determine whether the addition of nortriptyline to ECT enhances its efficacy and prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c5f01cc87054f00bf17d03a96c4c390
https://doi.org/10.1111/acps.13408
https://doi.org/10.1111/acps.13408
Publikováno v:
Acta psychiatrica Scandinavica
Acta Psychiatrica Scandinavica, 147(6), 561-569. Wiley-Blackwell Publishing Ltd
Acta Psychiatrica Scandinavica, 147(6), 561-569. Wiley-Blackwell Publishing Ltd
Objective: High relapse rates are observed after electroconvulsive therapy (ECT) for major depression. Identifying patients who are at increased risk for relapse to intensify their treatment regimen post-ECT might reduce relapse rates. We aimed to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8197a60d5272f5f2f49b161d37c236ce
https://repository.uantwerpen.be/docstore/d:irua:17308
https://repository.uantwerpen.be/docstore/d:irua:17308
Autor:
Astrid M. Kamperman, Esther M. Pluijms, Tom K. Birkenhäger, Witte J.G. Hoogendijk, Walter W. van den Broek
Publikováno v:
The Australian and New Zealand Journal of Psychiatry
Objective: The primary indication for electroconvulsive therapy is medication-resistant major depression. There is some evidence that combining electroconvulsive therapy with an antidepressant, instead of electroconvulsive therapy monotherapy, might
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798e54c5abc4ba3e9990784fafce1676
http://europepmc.org/articles/PMC8020309
http://europepmc.org/articles/PMC8020309
Autor:
Tom K. Birkenhäger, Esther M. Pluijms
Publikováno v:
Journal of Psychiatric Practice, 22(6), 478-480. Lippincott Williams & Wilkins
This report describes a 63-year-old woman, who had experienced 3 previous episodes of severe major depressive disorder. The first 2 episodes responded to treatment with antidepressants, whereas the third episode was accompanied by psychotic features
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c32cf8f9d7d086584dea884cbbe614c7
https://doi.org/10.1097/pra.0000000000000192
https://doi.org/10.1097/pra.0000000000000192
Autor:
Paul G.H. Mulder, Esther M. Pluijms, Tom K. Birkenhäger, Walter W. van den Broek, Michel R. Ju
Publikováno v:
Journal of Affective Disorders, 126(1-2), 257-261. Elsevier
Background: Several variables have been studied as possible predictors for the efficacy of ECT, results from the few studies assessing the influence of age on the efficacy of ECT were inconsistent. In older patients suffering from severe depression,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63068a1bd8e1277d40ce2c8dea032c98
https://doi.org/10.1016/j.jad.2010.02.131
https://doi.org/10.1016/j.jad.2010.02.131
Autor:
Jan A. Bruijn, Tom K. Birkenhäger, E. van Os, W.W. van den Broek, Paul G.H. Mulder, Esther M. Pluijms
Publikováno v:
Journal of Psychopharmacology, 23(6), 708-713. SAGE Publications Ltd
Abstract With respect to the pharmacological characteristic, venlafaxine is comparable with tricyclic antidepressants (TCAs), and venlafaxine might be comparable in efficacy. We performed a systematic review investigating the relative efficacy and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2816959ce00c8ca48d84c2d4972cf27
https://doi.org/10.1177/0269881108089821
https://doi.org/10.1177/0269881108089821
Autor:
Paul G.H. Mulder, Jan A. Bruijn, Esther M. Pluijms, Tom K. Birkenhäger, Theo H. N. Groenland, Ari Kusuma, Walter W. van den Broek
Publikováno v:
Current Drug Therapy. 2:121-126
In this review we want to summarize the results of the placebo-controlled randomized clinical trials with beta- blocking adrenergic agents during electroconvulsive therapy (ECT), and review the effect on seizure duration and cardio- vascular variable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a389677576952e4bdca9945492b76bcb
https://doi.org/10.2174/157488507780619022
https://doi.org/10.2174/157488507780619022
Publikováno v:
Journal of Affective Disorders, 90(2-3), 233-237. Elsevier
Background Longer duration of major depressive episode is supposed to decrease response to electroconvulsive therapy (ECT). Most studies on the subject are dated and their population differs from ours, therefore their results may not be applicable to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a439f5bc6de4a91fa2ba6b37c9af33a
https://doi.org/10.1016/j.jad.2005.11.010
https://doi.org/10.1016/j.jad.2005.11.010
Publikováno v:
Journal of Affective Disorders. 69:93-99
Background: Few studies assessing the influence of resistance to antidepressant pharmacotherapy on the response to subsequent electroconvulsive therapy (ECT) are found in the literature. Results are somewhat conflicting and may not be applicable to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57af22a95740343179723171f1dae00
https://doi.org/10.1016/s0165-0327(00)00378-5
https://doi.org/10.1016/s0165-0327(00)00378-5
Publikováno v:
Journal of ECT, 29(2), 137-138. Lippincott Williams & Wilkins
This report describes a 55-year-old woman who had 1 previous episode of major depression that responded favorably to treatment with tricyclic antidepressants. After the development of Addison disease, she experienced a new episode of major depression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e355fc27f0d883a9701f6fffc8f2a8a1
https://pubmed.ncbi.nlm.nih.gov/23377750
https://pubmed.ncbi.nlm.nih.gov/23377750